University of Delaware Professor Kristi Kiick is leading collaborative learn to invent original drug offer systems with the functionality to crimson meat up medication for illnesses that have an impact on connective tissues, such as osteoarthritis or rheumatoid arthritis, which is an autoimmune disease.
The learn team is working to program these nanoparticle carriers to selectively bind to degrading collagen in the body. Collagen is a protein that helps fleshy up or provide structure to connective tissue — the entire lot from our skin to our bones, tendons and ligaments.
When collagen degrades, as a outcomes of disease or hurt, the nanoparticles designed by the Kiick lab can attach and remain on the hurt save longer than many recent medication ideas. This permits for the chance of turning in save-explicit medicines over longer classes of time — from days to weeks.